Dr. Paolo Zamboni at the Subcommittee on Neurological Disease

On June 15th, 2010. See this statement in context.

June 15th, 2010 / 12:30 p.m.

Medical Doctor, Director, Vascular Diseases Center, University of Ferrara, As an Individual

Yes. I began this treatment in 2007. We had 50 relapsing-remitting patients who completed three years of follow-up. The result was that 75% of the relapsing-remitting patients did not have more relapses or more active lesions on the MRI and increased their quality of life. This was in three years.

See context to find out what was said next.